Medicine and Dentistry
Atrial Fibrillation
100%
Catheter Ablation
53%
Pulmonary Vein Isolation
37%
Paroxysmal Atrial Fibrillation
18%
Heart Failure
16%
Persistent Atrial Fibrillation
14%
Recurrent Disease
14%
Rapid Amplification of cDNA Ends
10%
Pulmonary Vein
10%
Apoplexy
9%
Implantable Automatic Defibrillator
9%
Antiarrhythmic Agent
9%
Sex Difference
9%
Cardiovascular System
9%
Catheter Ablation
8%
Idiopathic Ventricular Fibrillation
7%
Atrial Fibrillation Ablation
6%
Cardiac Dysrhythmia
6%
Heart Atrium Arrhythmia
5%
Phrenic Nerve
5%
Hazard Ratio
5%
Quality of Life
5%
Anticoagulation
5%
Keyphrases
Atrial Fibrillation
49%
Pulsed Field Ablation
21%
Heart Failure
18%
Atrial Fibrillation Ablation
15%
Pulmonary Vein Isolation
14%
Persistent Atrial Fibrillation
9%
Confidence Interval
9%
Sinus Rhythm
9%
Sex Differences
8%
Patients with Heart Failure
8%
Incident Atrial Fibrillation
8%
Heart Failure with Preserved Ejection Fraction (HFpEF)
8%
Implantable Cardioverter-defibrillator Shock
8%
Meta-analysis
7%
Hazard Ratio
7%
Rate Control
7%
Sex-related Differences
7%
Secondary Prevention
7%
Sudden Cardiac Death Prevention
7%
Cryoballoon Pulmonary Vein Isolation
7%
Clinical Outcomes
6%
Redo Surgery
6%
Ablation
6%
Risk Factors
5%
Dutch
5%
Quality of Life
5%
Beta-blockers
5%
Digoxin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
57%
Heart Failure
28%
Antiarrhythmic Agent
14%
Recurrent Disease
10%
Heart Ventricle Arrhythmia
8%
Paroxysmal Atrial Fibrillation
8%
Persistent Atrial Fibrillation
8%
Permanent Atrial Fibrillation
7%
Heart Failure with Reduced Ejection Fraction
7%
Congenital Heart Disease
5%
Symptom
5%
Sudden Cardiac Death
5%
Heart Arrhythmia
5%
